126 related articles for article (PubMed ID: 20151969)
21. Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3.
Pitchakarn P; Suzuki S; Ogawa K; Pompimon W; Takahashi S; Asamoto M; Limtrakul P; Shirai T
Food Chem Toxicol; 2012 Mar; 50(3-4):840-7. PubMed ID: 22266361
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors.
Szymanski KM; Wei JT; Dunn RL; Sanda MG
Urology; 2010 Nov; 76(5):1245-50. PubMed ID: 20350762
[TBL] [Abstract][Full Text] [Related]
23. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
24. Patient-reported Outcomes Following Treatment of Localised Prostate Cancer and Their Association with Regret About Treatment Choices.
van Stam MA; Aaronson NK; Bosch JLHR; Kieffer JM; van der Voort van Zyp JRN; Tillier CN; Horenblas S; van der Poel HG
Eur Urol Oncol; 2020 Feb; 3(1):21-31. PubMed ID: 31411965
[TBL] [Abstract][Full Text] [Related]
25. Factors Associated with Men's Assessment of Prostate Cancer Treatment Choice.
Ross LE; Howard DL; Bowie JV; Thorpe RJ; Kinlock BL; Burt C; LaVeist TA
J Cancer Educ; 2016 Jun; 31(2):301-7. PubMed ID: 25893926
[TBL] [Abstract][Full Text] [Related]
26. Assessment of quality of life after radical radiotherapy for prostate cancer.
Caffo O; Fellin G; Graffer U; Luciani L
Br J Urol; 1996 Oct; 78(4):557-63. PubMed ID: 8944512
[TBL] [Abstract][Full Text] [Related]
27. Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.
Xu J; Janisse J; Ruterbusch JJ; Ager J; Liu J; Holmes-Rovner M; Schwartz KL
Ann Fam Med; 2016 May; 14(3):208-14. PubMed ID: 27184990
[TBL] [Abstract][Full Text] [Related]
28. Patients' survival expectations before localized prostate cancer treatment by treatment status.
Mohan R; Beydoun H; Barnes-Ely ML; Lee L; Davis JW; Lance R; Schellhammer P
J Am Board Fam Med; 2009; 22(3):247-56. PubMed ID: 19429730
[TBL] [Abstract][Full Text] [Related]
29. Brachytherapy for prostate cancer: the patient's perspective.
Ward-Smith P
Urol Nurs; 2003 Jun; 23(3):213-7. PubMed ID: 12861739
[TBL] [Abstract][Full Text] [Related]
30. Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry.
Ten Ham RMT; Broering JM; Cooperberg MR; Carroll P; Wilson LS
Clin Genitourin Cancer; 2020 Feb; 18(1):e21-e27. PubMed ID: 31796344
[TBL] [Abstract][Full Text] [Related]
31. The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.
Pacyna JE; Kim S; Yost K; Sedlacek H; Petereit D; Kaur J; Rapkin B; Grubb R; Paskett E; Chang GJ; Sloan J; Basch E; Major B; Novotny P; Taylor J; Buckner J; Parsons JK; Morris M; Tilburt JC
BMC Cancer; 2018 Aug; 18(1):788. PubMed ID: 30081846
[TBL] [Abstract][Full Text] [Related]
32. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL;
BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
Wei JT; Dunn RL; Litwin MS; Sandler HM; Sanda MG
Urology; 2000 Dec; 56(6):899-905. PubMed ID: 11113727
[TBL] [Abstract][Full Text] [Related]
34. Information needs and prostate cancer: the development of a systematic means of identification.
Dale J; Jatsch W; Hughes N; Pearce A; Meystre C
BJU Int; 2004 Jul; 94(1):63-9. PubMed ID: 15217433
[TBL] [Abstract][Full Text] [Related]
35. Comparison of perspectives on prostate cancer: analyses of survey data.
Crawford ED; Bennett CL; Stone NN; Knight SJ; DeAntoni E; Sharp L; Garnick MB; Porterfield HA
Urology; 1997 Sep; 50(3):366-72. PubMed ID: 9301699
[TBL] [Abstract][Full Text] [Related]
36. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey.
Hall JD; Boyd JC; Lippert MC; Theodorescu D
Urology; 2003 Feb; 61(2):402-7. PubMed ID: 12597956
[TBL] [Abstract][Full Text] [Related]
37. [Quality of life in patients with prostate cancer: validation of an instrument for clinical practice].
Balbontín F; Marchetti P; Moreno S; Cabello JM; Urzúa C; Silva A; Avilés J; Badínez L; García J; Salgado A; Vinez E; Alliende I; Canals A; Velasco A
Arch Esp Urol; 2015 Jun; 68(5):466-73. PubMed ID: 26102050
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a revised instrument to assess the needs of men diagnosed with prostate cancer.
Duke JM; Treloar CJ; Byles JE
Support Care Cancer; 2005 Nov; 13(11):895-903. PubMed ID: 16025261
[TBL] [Abstract][Full Text] [Related]
39. How older patients' treatment preferences are influenced by disclosures about therapeutic uncertainty: surgery versus expectant management for localized prostate cancer.
Mazur DJ; Merz JF
J Am Geriatr Soc; 1996 Aug; 44(8):934-7. PubMed ID: 8708303
[TBL] [Abstract][Full Text] [Related]
40. Factors related to self-rated health and life satisfaction one year after radical prostatectomy for localised prostate cancer: a cross-sectional survey.
Talvitie AM; Ojala H; Tammela T; Koivisto AM; Pietilä I
Scand J Caring Sci; 2019 Sep; 33(3):688-697. PubMed ID: 30866074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
